Elite Pharmaceuticals, Inc. Noninterest Expense Directors Fees
Elite Pharmaceuticals, Inc. (ELTP) reported Noninterest Expense Directors Fees of $2.46 million for the 3-month period ending 2020-06-30, per its 10-Q filed 2020-08-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:NoninterestExpenseDirectorsFees · last filed 2020-08-14
- Elite Pharmaceuticals, Inc. noninterest expense directors fees for the quarter ending 2020-06-30 was $2.46M, a 44.22% increase year-over-year.
- Elite Pharmaceuticals, Inc. noninterest expense directors fees for the quarter ending 2020-03-31 was $201.25K.
- Elite Pharmaceuticals, Inc. noninterest expense directors fees for the quarter ending 2019-12-31 was $201.25K, a 50.00% decline year-over-year.
- Elite Pharmaceuticals, Inc. noninterest expense directors fees for the quarter ending 2019-09-30 was $201.25K.
- Elite Pharmaceuticals, Inc. noninterest expense directors fees for fiscal 2020 was $2.31M, a 657.79% increase from fiscal 2019.
- Elite Pharmaceuticals, Inc. noninterest expense directors fees for fiscal 2019 was $305.00K, a 76.54% decline from fiscal 2018.
- Elite Pharmaceuticals, Inc. noninterest expense directors fees for fiscal 2018 was $1.30M, a 550.00% increase from fiscal 2017.
- Elite Pharmaceuticals, Inc. noninterest expense directors fees for fiscal 2017 was $200.00K, a 99.86% increase from fiscal 2016.
| Period end | Noninterest Expense Directors Fees 3 month | Noninterest Expense Directors Fees 6 month | Noninterest Expense Directors Fees 9 month | Noninterest Expense Directors Fees 12 month |
|---|---|---|---|---|
| 2020-06-30 | $2.46M 10-Q · filed 2020-08-14 | $2.66M derived: sum of 2 quarters · filed 2020-08-14 | $2.87M derived: sum of 3 quarters · filed 2020-08-14 | $3.07M derived: sum of 4 quarters · filed 2020-08-14 |
| 2020-03-31 | $201.25K derived: 10-K 12 month − 10-Q 9 month · filed 2020-06-29 | $402.50K derived: sum of 2 quarters · filed 2020-06-29 | $603.75K derived: sum of 3 quarters · filed 2020-06-29 | $2.31M 10-K · filed 2020-06-29 |
| 2019-12-31 | $201.25K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-02-10 | $402.50K derived: sum of 2 quarters · filed 2020-02-10 | $2.11M 10-Q · filed 2020-02-10 | $1.11M derived: sum of 4 quarters · filed 2020-02-10 |
| 2019-09-30 | $201.25K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-11-12 | $1.91M 10-Q · filed 2019-11-12 | $908.75K derived: sum of 3 quarters · filed 2019-11-12 | $1.31M derived: sum of 4 quarters · filed 2019-11-12 |
| 2019-06-30 | $1.71M 10-Q · filed 2019-08-09 | $707.50K derived: sum of 2 quarters · filed 2019-08-09 | $1.11M derived: sum of 3 quarters · filed 2019-08-09 | $1.11M derived: sum of 4 quarters · filed 2019-08-09 |
| 2019-03-31 | -$1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-06-21 | -$597.50K derived: sum of 2 quarters · filed 2019-06-21 | -$597.50K derived: sum of 3 quarters · filed 2019-06-21 | $305.00K 10-K · filed 2019-06-21 |
| 2018-12-31 | $402.50K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-02-11 | $402.50K derived: sum of 2 quarters · filed 2019-02-11 | $1.30M 10-Q · filed 2019-02-11 | $1.78M derived: sum of 4 quarters · filed 2019-02-11 |
| 2018-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-11-09 | $902.50K 10-Q · filed 2018-11-09 | $1.37M derived: sum of 3 quarters · filed 2018-11-09 | $1.58M derived: sum of 4 quarters · filed 2018-11-09 |
| 2018-06-30 | $902.50K 10-Q · filed 2018-08-09 | $1.37M derived: sum of 2 quarters · filed 2018-08-09 | $1.58M derived: sum of 3 quarters · filed 2018-08-09 | $1.79M derived: sum of 4 quarters · filed 2018-08-09 |
| 2018-03-31 | $471.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-06-14 | $678.25K derived: sum of 2 quarters · filed 2018-06-14 | $885.50K derived: sum of 3 quarters · filed 2018-06-14 | $1.30M 10-K · filed 2018-06-14 |
| 2017-12-31 | $207.25K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-02-09 | $414.50K derived: sum of 2 quarters · filed 2018-02-09 | $829.00K 10-Q · filed 2018-02-09 | $195.83K derived: sum of 4 quarters · filed 2018-02-09 |
| 2017-09-30 | $207.25K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-11-09 | $621.75K 10-Q · filed 2017-11-09 | -$11.42K derived: sum of 3 quarters · filed 2017-11-09 | $196.83K derived: sum of 4 quarters · filed 2017-11-09 |
| 2017-06-30 | $414.50K 10-Q · filed 2017-08-09 | -$218.67K derived: sum of 2 quarters · filed 2017-08-09 | -$10.42K derived: sum of 3 quarters · filed 2017-08-09 | $195.33K derived: sum of 4 quarters · filed 2017-08-09 |
| 2017-03-31 | -$633.17K derived: 10-K 12 month − 10-Q 9 month · filed 2017-06-14 | -$424.92K derived: sum of 2 quarters · filed 2017-06-14 | -$219.17K derived: sum of 3 quarters · filed 2017-06-14 | $200.00K 10-K · filed 2017-06-14 |
| 2016-12-31 | $208.25K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-02-09 | $414.00K derived: sum of 2 quarters · filed 2017-02-09 | $833.17K 10-Q · filed 2017-02-09 | |
| 2016-09-30 | $205.75K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-11-09 | $624.92K 10-Q · filed 2016-11-09 | ||
| 2016-06-30 | $419.17K 10-Q · filed 2016-08-09 | |||
| 2016-03-31 | $100.07K 10-K · filed 2016-06-15 | |||
| 2015-03-31 | $110.00K 10-K · filed 2016-06-15 | |||
| 2014-12-31 | $110.00K 10-K · filed 2015-06-15 | |||
| 2014-03-31 | $27.50K 10-K · filed 2014-06-30 | $110.00K 10-K · filed 2016-06-15 | ||
| 2013-12-31 | $110.00K 10-K · filed 2015-06-15 | |||
| 2013-03-31 | $27.50K 10-K · filed 2013-06-21 | |||
| 2012-12-31 | $130.00K 10-K · filed 2014-06-30 | |||
| 2011-12-31 | $130.00K 10-K · filed 2013-06-21 |